← Leaderboards
William S Messer
University Of Toledo
$1,430,558
Attributed
$1,430,558
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $229.9K · FY2005–07$250K$187.5K$125K$62.5K$0
'05
'06
'07
Funding mix
By agency
NIH$1,430,558 · 1
By mechanism
R01$1,430,558 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Toledo
Same institution · by research overlap
- William R Taylor$2,273,061
Others in their field
Top investigators on “Cholinergic Agents”
- Paul S. Aisen · Cognition Therapeutics, Inc.$15,037,356
- Paul A. Newhouse · University Of Vermont &St Agric College$12,662,349
- Palmer W Taylor · University Of California San Diego$11,298,761
- Thomas Scott Stroup · University Of North Carolina Chapel Hill$9,939,044
- Doodipala Samba Reddy · North Carolina State University Raleigh$9,706,425
- P Jeffrey Conn · Vanderbilt University$9,312,998
Research focus
Cholinergic AgentsDrug Design /Synthesis /ProductionDrug Screening /EvaluationMuscarinic ReceptorLigandsReceptor BindingTissue /Cell CultureNonhuman Therapy EvaluationLaboratory RatBehavior TestMemory DisordersChemical Structure FunctionMethylphenyltetrahydropyridinePharmacokineticsBrain Disorder ChemotherapyThiazolesAlzheimer'S DiseaseChemical SynthesisDementiaClone CellsBinding SitesMolecular DynamicsSchizophreniaCell Line
Grant awards (7)
Muscarinic agonists for neurological disorders$217,952
R01 · FY2007 · NS · contact PI
Muscarinic agonists for neurological disorders$224,461
R01 · FY2006 · NS · contact PI
Muscarinic agonists for neurological disorders$229,863
R01 · FY2005 · NS
Muscarinic agonists for neurological disorders$229,863
R01 · FY2004 · NS
DEVELOPMENT OF NOVEL MUSCARINIC AGONISTS$181,370
R01 · FY2002 · NS
DEVELOPMENT OF NOVEL MUSCARINIC AGONISTS$176,091
R01 · FY2001 · NS
DEVELOPMENT OF NOVEL MUSCARINIC AGONISTS$170,958
R01 · FY2000 · NS